May 7, 2019 : DCMS #448

TOP STORIES — Diabetes News and Research

Blood Pressure or Glucose: Which to Treat More Aggressively?

Prostate Drugs Increase Diabetes Risk

Not Only SGLT-2 Inhibitors to Prevent CVD

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Kevin Sayer on CGMs and the Future of Diabetes Management

MOST POPULAR ARTICLES OF THE MONTH

#1 Metformin Associated with Vitamin B Deficiency and Cognitive Impairment

#2 Metformin For People Who Do Not Have Diabetes?

#3 Meds That Impact Your Exercise As A Person With Diabetes

This week we focus on the relationship of diabetes and hypertension. Our main feature looks at the value of aggressive treatment of hypertension in both type 1 and type 2 diabetes, and why tight control is beneficial. Our item 3 looks how metformin, in addition to the use of an SGLT-2 inhibitor, can very much benefit those same patients. 

Dave Joffe

Editor-in-chief

Is one more important than the other?

Study results should be explained to men being treated for BPH with dutasteride or finasteride.

Another medication taken for type 2 diabetes may also help reverse a potentially life-threatening heart condition.

In this Exclusive Interview, Kevin Sayer  talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the Dexcom G6 CGM System and how the future of CGM will affect the way not only type 1, but also type 2 and prediabetes are treated.